Generic drug sponsors are looking for help from the FDA to "save" bioequivalence studies interrupted by coronavirus or other problems. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
